Pifetol 200 Tablet contains Pirfenidone 200 mg, an anti-fibrotic and anti-inflammatory agent used to manage idiopathic pulmonary fibrosis (IPF). It helps slow the progression of lung scarring, improving patients’ quality of life and pulmonary function.
Belonging to the pulmonology and anti-fibrotic segment, Pirfenidone is prescribed by pulmonologists for patients diagnosed with chronic fibrotic lung conditions. Its efficacy in reducing fibrosis makes it a critical therapy in specialized respiratory care centers.
The tablet works by modulating inflammatory mediators and fibroblast activity, which slows the development of fibrotic tissue in the lungs, supporting long-term respiratory health.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Pifetol 200 Tablet provides a profitable B2B opportunity, catering to hospitals, clinics, and specialized pulmonology units across India.